dc.contributorUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2019-10-06T16:02:51Z
dc.date.accessioned2022-12-19T18:41:00Z
dc.date.available2019-10-06T16:02:51Z
dc.date.available2022-12-19T18:41:00Z
dc.date.created2019-10-06T16:02:51Z
dc.date.issued2018-01-01
dc.identifierJournal of Craniofacial Surgery, v. 29, n. 6, p. e555-e556, 2018.
dc.identifier1536-3732
dc.identifier1049-2275
dc.identifierhttp://hdl.handle.net/11449/188274
dc.identifier10.1097/SCS.0000000000004538
dc.identifier2-s2.0-85055614807
dc.identifier1527011976590326
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/5369312
dc.description.abstractMyiasis has been defined as a pathologic condition where dipterous larvae are lodged in mammalian hosts causing an infestation, which feeds on living or dead tissue for at least a certain period inside the host and develops itself as parasites. In humans, the most commonly affected sites are the nose, eyes, skin wounds, sinuses, lungs, ears, gut, gall bladder, vagina, nasal cavities, and rarely the mouth because the oral tissues are rarely exposed to the external environment. The etiology of oral myiasis is usually related to local factors such as poor oral hygiene, periodontal disease and labial incompetence, and systemic factors such as neurologic deficits.
dc.languageeng
dc.relationJournal of Craniofacial Surgery
dc.rightsAcesso restrito
dc.sourceScopus
dc.subjectAIDS serodiagnosis
dc.subjectCerebral
dc.subjectIvermectin
dc.subjectMyiasis
dc.subjectToxoplasmosis
dc.titleOral myiasis in a patient with HIV manifestations and neurologic toxoplasmosis treated by ivermectin
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución